| | | | | | | | | | |
|
| |
|
| Dockets Entered
On May 17, 2006
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| 2006P-0210
|
| Petition requesting FDA amend its regulations for products composed of engineered nanoparticles generally and sunscreen drug products composed of engineered nanoparticles specifically
|
|
|
|
|
| 2006P-0212
|
| Lasik due to the use of research from experiments conducted on human beings without proper basis to believe it is in the patients best interests and improper patient informed consent
|
|
|
|
|
| 2006P-0213
|
| enforce the single-use requirement for all Microkeratomes and their components used by Lasik
|
|
|
|
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
| ACK 18
|
| FDA/DDM to The International Center for Technology Assessment
|
| Vol #:
|
| 151
|
|
|
|
|
| CP 17
|
| The International Center for Technology Assessment
|
| Vol #:
|
| 151
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET 17639
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 162
|
|
|
|
|
| LET 17640
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 162
|
|
|
|
|
| LET 17641
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 162
|
|
|
|
|
| LET 17642
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 162
|
|
|
|
|
| LET 17643
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 162
|
|
|
|
|
| LET 17644
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 162
|
|
|
|
|
| LET 17645
|
| GNLD International, LLC
|
| Vol #:
|
| 162
|
|
|
|
|
| LET 17646
|
| Davisco Foods International, Inc.
|
| Vol #:
|
| 162
|
|
|
|
|
| LET 17647
|
| Davisco Foods International, Inc.
|
| Vol #:
|
| 162
|
|
|
|
|
| LET 17648
|
| New Product Development Sedona Laboratories, Inc.
|
| Vol #:
|
| 162
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| C 9403
|
| J. Redding
|
| Vol #:
|
| 134
|
|
|
|
|
| C 9404
|
| R. Peterson
|
| Vol #:
|
| 134
|
|
|
|
|
| C 9405
|
| M. Nelson
|
| Vol #:
|
| 134
|
|
|
|
|
| C 9406
|
| Mrs. C. Arnold
|
| Vol #:
|
| 134
|
|
|
|
|
| C 9407
|
| H. Hopper
|
| Vol #:
|
| 134
|
|
|
|
|
| C 9408
|
| L. W. Beville
|
| Vol #:
|
| 134
|
|
|
|
|
| C 9409
|
| B. Olson
|
| Vol #:
|
| 134
|
|
|
|
|
| C 9410
|
| A. Arbini
|
| Vol #:
|
| 134
|
|
|
|
|
| C 9411
|
| SA. Kamps
|
| Vol #:
|
| 134
|
|
|
|
|
| C 9412
|
| L. Florke
|
| Vol #:
|
| 134
|
|
|
|
|
| C 9413
|
| L. Yeretzian
|
| Vol #:
|
| 134
|
|
|
|
|
| C 9414
|
| R. A. Moore
|
| Vol #:
|
| 134
|
|
|
|
|
| C 9415
|
| Mrs. J. Zawawi
|
| Vol #:
|
| 134
|
|
